Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

GlaxoSmithKline Nigeria Profit Little Changed as Revenue Climbs

Oct. 28 (Bloomberg) -- GlaxoSmithKline Nigeria Plc posted net income of 1.672 billion naira for the nine months to Sept. 30, little changed from 1.668 billion naira a year earlier.

Revenue for the period climbed to 15.84 billion naira from 12.8 billion naira, the company said in a statement published on the website of the Nigerian Stock Exchange today.

Link to Company News:{GLAXOSMI NL <Equity> CN <GO>} Link to Company News:{GSK LN <Equity> CN <GO>}

To contact the editor responsible for this story: Alastair Reed at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.